Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
2 hedge funds and large institutions have $228K invested in Cyclo Therapeutics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
50% less capital invested
Capital invested by funds: $459K → $228K (-$231K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.75K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WVP
1
Worth Venture Partners
Fort Lee,
New Jersey
| $223K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $5K | +$6.75K | +1,865 | +910% |
|
CYTHW Hedge Fund Activity: Q3 2021 in Review
2 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q3 2021, worth a combined $228K — down 50% from $459K a quarter earlier.
Fund positioning in CYTHW was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $6.75K.
- 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $228K of Cyclo Therapeutics, Inc. Warrant stock for Q3 2021, down 50% quarter-over-quarter.
- 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q3 2021 and 0 closed out.
- The largest Cyclo Therapeutics, Inc. Warrant buyer in Q3 2021 was UBS Group, an estimated $6.75K added.
Based on aggregated 13F filings for Q3 2021.